Tag:
ALS
Latest Headlines
Latest Headlines
Biogen Idec bets it can succeed on a risky Phase III ALS gamble
Bloomberg biotech scribe Meg Tirrell has been plumbing Biogen Idec's late-stage drug for ALS and finds some good reasons to believe that they are on to something big.
Cytokinetics offers upbeat data from mid-stage trial of ALS drug
After failing to impress investors with previous data on its ALS drug, Cytokinetics' ( $CYTK ) stock price got a 4% bump this morning after the South San Francisco developer revealed data from a
Neuron implants fix broken brain circuitry in obese mice
Harvard University researchers and their colleagues have brought new hope to the regenerative medicine field in the aftermath of drug developer Geron's ( $GERN ) high-profile move to kill its stem cell
Small ALS stem cell study takes a big step forward
Investigators led by Eva Feldman, a neurologist at the University of Michigan, have been given the green light to take another step forward in a small but very closely watched clinical trial of a new...
At last, a cause found for Lou Gehrig's disease
On July 4, 1939, a young man in his 30s held a retirement party. He stood in a pinstripe uniform before an adoring, emotional crowd at Yankee Stadium and declared himself "the luckiest man on the
Early-stage ALS stem cell study clears initial safety hurdle
A very small, early-stage clinical trial of a new fetal stem cell therapy for amyotrophic lateral sclerosis, better known as Lou Gehrig's disease, is hinting at its potential success. A team of
RXi, UMMS get ALS research funding
Three philanthropic organizations dedicated to finding a treatment for ALS, also known as Lou Gehrig's Disease, have financed a new collaboration between RXi Pharmaceuticals and University of
Scientists tout promising results from new ALS animal study
An enzyme known as activated protein C, or APC, was able to significantly prolong the lives of mice involved in a study of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease.
Stem cell study improves survival of ALS animals
Investigators at the University of Wisconsin have made a key breakthrough in the use of adult stem cells to treat ALS. By injecting
Stem cell breakthrough propels research on ALS
A research team from Columbia and Harvard was able to reprogram stem cells taken from the skin of elderly patients into cells responsible for triggering amyotrophic lateral sclerosis, or ALS. In one
